enGene Holdings Inc. (ENGN) Financials
ENGN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| July 31, 2026 | 288.3 million | 58.0 million |
| April 30, 2026 | 307.5 million | 52.4 million |
| Jan. 31, 2026 | 337.1 million | 55.6 million |
| Oct. 31, 2025 | 221.5 million | 53.8 million |
ENGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| July 31, 2026 | -18.9 million | 7.8 million |
| April 30, 2026 | -30.6 million | 4.1 million |
| Jan. 31, 2026 | -29.1 million | 2.8 million |
| Oct. 31, 2025 | -25.4 million | 2.6 million |
ENGN Net Income
No data available :(
ENGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| July 31, 2026 | 266.3 million | 25.2 million | 5.7 million |
| April 30, 2026 | 258.5 million | 24.9 million | 6.0 million |
| Jan. 31, 2026 | 275.9 million | 24.7 million | 6.2 million |
| Oct. 31, 2025 | 193.8 million | 15.3 million | 6.5 million |
ENGN Shares Outstanding
ENGN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| July 31, 2026 | - | 20.1 million | 13.9 million | - |
| April 30, 2026 | 98000 | 22.2 million | 9.8 million | - |
| Jan. 31, 2026 | 153000 | 22.3 million | 8.9 million | - |
| Oct. 31, 2025 | 437000 | 31.7 million | 10.0 million | - |
ENGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| July 31, 2026 | - | 178000 |
| April 30, 2026 | - | 180000 |
| Jan. 31, 2026 | - | 189000 |
| Oct. 31, 2025 | - | 171000 |
ENGN
Price: $1.68
52 week price:
Earnings Per Share: -2.07 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 130.0 million